Heartseed
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
All edits
Edits on 17 Feb, 2024
Amy Sar
Amy Sar
Edits made to:
Infobox (+1 properties)
Heartseed
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
Infobox
LinkedIn URL
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-2 properties)
Infobox
Official Website
Official Website
Edits on 6 Apr, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 6 Dec, 2022
Golden AI
Edits on 16 Jun, 2022
Golden AI
Edits on 8 Apr, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patents assigned (count)
1
Edits on 17 Feb, 2022
Keeri Tramm
Edits made to:
Infobox (+2 properties)
Description (+115 characters)
Heartseed
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
Infobox
Industry
Website
Edits on 25 Nov, 2021
Blessing Nwodo
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 25 Nov, 2021
Jen English
Edits made to:
Infobox (+1 properties)
Infobox
Company status
Active
Katrina-Kay Pettitt
Edits made to:
Infobox (+6 properties)
Infobox
Country
Email address
contact@heartseed.jp
Location
Edits on 17 Aug, 2021
Golden AI
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
37,000,000
Total funding amount (USD)
63,000,000
Golden AI
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Latest funding round date
June 11, 2021
Latest funding type
Total funding amount (USD)
37,000,000
Golden AI
Edits made to:
Infobox (+3 properties)
Heartseed
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
Infobox
Find more companies like Heartseed
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
